Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
356.50M | 359.10M | 336.60M | 253.80M | 73.20M | 329.30M | Gross Profit |
125.10M | 138.30M | 142.20M | 99.00M | 13.70M | 111.20M | EBIT |
33.50M | 27.70M | 10.90M | 26.90M | -99.80M | 2.00M | EBITDA |
52.70M | 55.00M | 49.60M | 48.60M | -22.20M | 43.10M | Net Income Common Stockholders |
10.50M | 9.10M | 7.90M | 7.10M | -48.20M | 160.90M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
10.20M | 12.20M | 14.10M | 15.60M | 17.10M | 20.30M | Total Assets |
720.00M | 722.60M | 732.60M | 749.70M | 746.80M | 803.60M | Total Debt |
208.40M | 209.60M | 218.70M | 228.20M | 325.10M | 312.10M | Net Debt |
277.20M | 197.40M | 204.60M | 212.60M | 308.00M | 291.80M | Total Liabilities |
277.20M | 291.30M | 290.00M | 300.50M | 367.30M | 376.80M | Stockholders Equity |
442.80M | 431.30M | 442.60M | 449.20M | 379.50M | 426.80M |
Cash Flow | Free Cash Flow | ||||
29.20M | 41.10M | 16.80M | 45.40M | -35.80M | -34.60M | Operating Cash Flow |
54.00M | 68.30M | 47.50M | 71.20M | -19.30M | 13.00M | Investing Cash Flow |
-15.40M | -27.20M | -14.70M | -15.80M | -5.40M | 156.40M | Financing Cash Flow |
-48.80M | -43.00M | -34.30M | -56.90M | 21.50M | -160.10M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | £1.69B | 9.92 | 6.90% | ― | 1.95% | 275.56% | |
73 Outperform | £799.95M | 14.12 | 16.38% | 0.54% | 3.70% | 57.10% | |
72 Outperform | £513.40M | 61.09 | 1.27% | 2.39% | 16.73% | -55.22% | |
67 Neutral | £8.11M | 7.90 | 7.73% | 3.58% | 2.07% | ― | |
67 Neutral | £265.71M | 5.97 | 10.69% | ― | 0.50% | ― | |
65 Neutral | $8.88B | 15.01 | 4.67% | 6.15% | 3.61% | -2.60% | |
63 Neutral | £336.46M | ― | 3.84% | ― | ― |